Phase I dose-escalation study of helical intensity-modulated radiotherapy-based stereotactic body radiotherapy for hepatocellular carcinoma.(2016)

Clinical outcomes and dosimetric study of hypofractionated Helical TomoTherapy in breast cancer patients.(2019)

The use of helical tomotherapy in the treatment of early stage breast cancer: indications, tolerance, efficacy—a single center experience.(2018)

Short course radiotherapy with simultaneous integrated boost for stage I-II breast cancer, early toxicities of a randomized clinical trial.(2012)

Long-Term Outcomes of Once-Daily Accelerated Partial-Breast Irradiation With Tomotherapy: Results of a Phase 2 Trial.(2021)

Use of helical tomotherapy in locally advanced and/or metastatic breast cancer for locoregional treatment. (2018)

Skin Toxicity in Early Breast Cancer Patients Treated with Field-In-Field Breast Intensity-Modulated Radiotherapy versus Helical Inverse Breast Intensity-Modulated Radiotherapy: Results of a Phase III Randomised Controlled Trial.(2021)

Cardiac Sparing with Personalized Treatment Planning for Early-stage Left Breast Cancer.(2020)

Clinical Outcomes of Several IMRT Techniques for Patients With Head and Neck Cancer: A Propensity Score–Weighted Analysis.(2017)